Radnor, PA., September 4, 2014 – Based on results from recent animal studies demonstrating more than 60% dose reduction with clinically impressive images, ControlRad Systems, a medical device company developing innovative products to dramatically reduce radiation exposure and risk for patients and physicians performing fluoroscopic procedures, has been invited to present at the Interventional Innovation Session at TCT 2014. The session is scheduled for September 14th between 2 and 6pm at the Walter E. Washington Convention Center.
ControlRad is a privately-held medical technology company developing innovative products that dramatically reduce the lifetime risk of radiation exposure from fluoroscopically guided interventional procedures (FGIP) for patients and healthcare professionals. These products are designed to improve safety without compromising image quality or workflow. This is accomplished with an integrated set of proprietary components which optimize the X-ray beam to deliver optimal image quality in the clinically-relevant region of focus of the physician while maintaining appropriate resolution in the periphery. ControlRad is headquartered in Philadelphia and has engineering development facilities in Kfar Saba, Israel. For more information, visit www.controlrad.com.